3D Cell Culture Market Historical Data and Future Scope

The Global 3D Cell Culture Market size is poised to expand at a 25.50% CAGR from 2017-2023 (forecast period), as per the latest findings of a report by Market Research Future (MRFR). It stood at USD 725.15 million in 2016 and will expand to a higher worth by 2023.

Rising cases of cancer, demand for organ transplantation, approval from government agencies, and awareness among patients are factors expected to drive the market growth exponentially. Emerging applications of 3D cell culture in pharmaceuticals and biotechnology industries is expected to open up growth opportunities for the market. The natural capacity of the technology to be more effective than cell lines is tantamount in driving its growth.

3D Cell Culture Market Overview

Emergence of new virulent strains have led to scientists developing drastic measures to counterattack these microbial enemies. 3D cell culture is a technique used to create environments for cells to flourish. These cells can be used in advanced medical methods such as drug toxicology screening, organ and tissue regeneration and more.

Get Exclusive Sample Copy of 3D Cell Culture Market Report Spread Across 100 Premium Pages, 16 Companies and Supported with Respective 280 Tables and Figures is Available at https://www.marketresearchfuture.com/sample_request/5928

Competition Analysis

Top players operating in the 3D cell culture market include Kuraray Co. Ltd., Merck KGaA, Lonza, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., Corning Incorporated, and others. Others include 3D Biotek LLC, Synthecon, Inc., Global Cell Solutions Inc., InSphero, Lena Biosciences Inc., The Electrospinning Company, ReproCELL Europe Ltd., Tecan Trading AG, and Charles River Laboratories. Partnerships and collaborations with laboratories are strategies being employed by these players to gain a larger share of the market.

Drug Discovery to be the Major Application

The 3D cell culture market is segmented on the basis of product, technique, application, and end-user.

Products are bifurcated into two main segments – instruments and consumables. The instrument segment is sub-segmented into cell culture chips, flow cytometer, and bioreactor. Similarly, the consumables segment is segmented into 3D multiwell plates, reagents, culture media, and glassware. The consumables segment is expected to exhibit a healthy 25.88% CAGR during the forecast period.